Overview GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures Status: Withdrawn Trial end date: 2008-03-01 Target enrollment: Participant gender: Summary Study to determine drug interactions between GW273225 and the anticonvulsants valproate, carbamazepine or phenytoin Phase: Phase 2 Details Lead Sponsor: GlaxoSmithKline